FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/060380 [Registered on: 30/11/2023] Trial Registered Prospectively
Last Modified On: 03/10/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Preventive
Screening
Dentistry
Behavioral 
Study Design  Cluster Randomized Trial 
Public Title of Study   Effectiveness of an intervention package (oral self-examination, oral scrape cytology based screening and mHealth) to increase the oral cancer screening 
Scientific Title of Study   Development, field trial, effectiveness and economic evaluation of an integrated public health intervention package to increase the screening of oral cancer among adults residing in two districts of Madhya Pradesh mixed methods implementation research study 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sana Anwar 
Designation  PhD scholar 
Affiliation  AIIMS Bhopal 
Address  Department of Community and Family Medicine, 2nd Floor, Hospital building, AIIMS Bhopal, Saket Nagar, Bhopal

Bhopal
MADHYA PRADESH
462020
India 
Phone  9818526196  
Fax    
Email  sana.phd2022@aiimsbhopal.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Anindo Majumdar 
Designation  Associate Professor 
Affiliation  AIIMS Bhopal 
Address  Department of Community and Family Medicine, Room no 16 2nd Floor, Hospital building, AIIMS Bhopal, Saket Nagar, Bhopal
Department of Community and Family Medicine, Room no 16 2nd Floor, Hospital building, AIIMS Bhopal, Saket Nagar, Bhopal
Bhopal
MADHYA PRADESH
462020
India 
Phone  9487635186  
Fax    
Email  anindo.cfm@aiimsbhopal.edu.in  
 
Details of Contact Person
Public Query
 
Name  Sana Anwar 
Designation  PhD scholar 
Affiliation  AIIMS Bhopal 
Address  Department of Community and Family Medicine, 2nd Floor, Hospital building, AIIMS Bhopal, Saket Nagar, Bhopal

Bhopal
MADHYA PRADESH
462020
India 
Phone  9818526196  
Fax    
Email  sana.phd2022@aiimsbhopal.edu.in  
 
Source of Monetary or Material Support  
All India Institute of Medical Sciences ( AIIMS), Bhopal 
 
Primary Sponsor  
Name  Dr. Sana Anwar 
Address  Department of community and family medicine,medical college building saket nagar, AIIMS Bhopal, Bhopal- 462020 
Type of Sponsor  Other [pricipal investigator ( Dr. Sana Anwar)] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sana Anwar  AIIMS Bhopal  Department of community and family medicine, second floor, Senior resident room, Medical college building , Saket Nagar, AIIMS Bhopal Bhopal. 462020
Bhopal
MADHYA PRADESH 
9818526196

sana.phd2022@aiimsbhopal.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Human Ethics Committee- student research ( IHEC- SR, AIIMS Bhopal)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C148||Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  intervention arm  oral self-examination, oral scrape cytology based screening and mHealth). total duration of intervention is 1 year 
Comparator Agent  usual care arm  usual clinical care  
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. Adults aged 30 years and above
2. Residing in the field practice areas of selected urban PHCs (UPHCs) which are not under CUHA, selected UPHCs under CUHA and PHC and CHC under CRHA. for most of the last six months.
3. Either owning a mobile phone themselves or having at least one member of their family living in the same household owning a mobile phone. 
 
ExclusionCriteria 
Details  1. Persons living with diagnosed oral cancer and currently on treatment.
2. Participants not present at home even after two follow up visits during initial recruitment and post intervention follow up survey.
3. Those refusing consent for the study. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Percentage change in number of screened population positive for both OSE & oral scrape cytology screening, population screened positive in OSE, number of OSE positive self referring themselves for oral scrape cytology screening, Proportion of population screened positive in OSE & underwent oral scrape cytology screening, number of cytology positive selfreferring & referral by ASHA, change in level of awareness, knowledge, attitude & skills, frequency of OSE ,proportion of calls to ASHA, delayed calls, population receiving pamphlets & videos from ASHA ,reach, adoption, fidelity & implementation cost.  Baseline data collection starts at 0 months .
Follow up after 12 months 
 
Secondary Outcome  
Outcome  TimePoints 
no secondary outcomes  no secondary outcomes 
 
Target Sample Size   Total Sample Size="240"
Sample Size from India="240" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Introduction and Rationale-

Oral cancer is sixth common malignancy globally, while in India, it is third most common malignancy with a five-year survival rate of 52% indicating that most of the cases  are identified later at an advanced stage. Thus, early detection is critical for improving the survival rates. Oral cancers are usually preceded by potentially malignant disorders which are generally asymptomatic at their initiation and may be detected by clinicians on routine oral  visual examination (OVE) and by people themselves through oral self examination (OSE). OSE has been endorsed by NPCDCS as well, which is the flagship programme of government of India for addressing NCDs. Screening is usually recommended once in 5 years but NFHS 4 and 5 data indicates low screening rates in Madhya Pradesh. Review of Indian studies have shown that, oral cancer screening through OSE and oral scrape cytology is a useful screening adjunct to conventional OVE for early detection  of oral cancer and is simple, easy to use, minimal patient discomfort, good patient acceptance, non invasive , cost effective, less time consuming, minimum manpower and equipment requirement. Community Health Officers(CHOs) posted in sub centres and staff nurses posted in PHC with some training can easily be taught how to perform sample collection for oral scrape cytology-based screening for early identification of oral cancer.

Primary objective

1.) To find out the effectiveness, and to conduct economic and implementation evaluation of an integrated public health intervention package (oral self-examination, oral scrape cytology based screening and m Health) for increasing screening for oral cancer among adults aged 30 years and above.

2.) To conduct a situational analysis to document oral cancer screening practices, and to understand  barriers and facilitators with respect to screening, diagnosis, treatment and referral of oral cancer as reported by the different stakeholders involved.

Secondary objective

To find out the socio-demographic, clinical, behavioural, environmental and health system predictors of oral cancer screening.

Methodolgy- mixed-methods intervention design with cluster randomized trial in  community. Qualitative component includes in depth interviews (IDIs) and key informant interview (KIIs) and quantitative component includes cross-sectional survey and semi-structured interviews, questionnaire based survey and health facility survey to be carried out among the healthcare facilities (both government and private) of Bhopal and Raisen district on adults aged 30 years and above . Final sample is 240 i.e. 120 in each arm. ASHAs will be trained for OSE and CHOs for collection of oral scrape cytology sample by the candidate.  The pragmatic cluster randomized trial will be conducted for nine months in three phases. Phase 1(situational analysis), phase 2 (implementation and trial of the complex intervention for oral cancer screening), phase 3(Evaluation of the intervention). Outcome measures will be percentage change in number of screened population, self referral practices, people undergoing oral scrape cytology and change in level of awareness, knowledge, attitude and skills between aged ≥ 30 years) in the intervention arm as compared to usual care arm.

Ethical Consideration- LOP for thesis proposal has been obtained from institutional human ethics committee.

 
Close